JPRN-UMIN000044348已完成未知
The efficacy of Azimycin 1% eye drops on the diagnosis and observation around the eyelids of patients with blepharitis - The efficacy of Azimycin 1% eye drops on the diagnosis and observation around the eyelids of patients with blepharitis
Shimazaki eye clinic/Tokyo Dental College Ichikawa General Hospital0 个研究点目标入组 30 人开始时间: 2021年5月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who understands the contents of the consent document and is able to consent in the document of the person. 2. Age of 20 years or older. 3. Patients who were defined as bacterial blepharitis at the administration start date, and with a score of 1 or more of eyelid redness/eyelid margin redness. 4. Patient who are judged to be needed to administration of azithromycin eye drops for treatment of blepharitis with MGD symptoms. 5. Patients who have all symptoms and findings shown below. Subjective symptoms Abnormal findings around openings of meibomian glands Plugging of meibomian glands 6. Patients who are judged to have symptoms of hypersecretory type MGD. 1. Patients with suspected fungal, viral, or Acanthamoeba. 2. Patients with suspected allergic conjunctivitis. 3. History of recurrent corneal erosion. 4. Any corneal epithelial loss, specifically any corneal ulcer (except for superficial punctate keratitis). 5. Patients who need to use any antibiotic, anti-inflammatory drug, vasoconstrictors, antihistamine, anti-allergic drug, disinfectant, proteolytic enzyme, herbal medicine (systemic topical, or dermally around eyelid), or treatment for MGD symptom (warm compress or lid hygiene) during the study. 6. Patients who will change the therapeutic medication for dry eye during the study. 7. Use of any corticosteroid, nonsteroidal anti-inflammatory drug, immunosuppressant (systemic, topical, or dermally around eyelid) within 1 week of enrollment. 8. Patients use Azimycin 1% eye drops within the past 45 days. 9. History of eye lid surgery within the past 90 days. 10. Known hypersensitivity or adverse effect to azithromycin, other macrolides, or to any of the drug ingredients in the study medications. 11. Participation in any other clinical study within the past 90 days or planning to participation in other clinical studies. 12. In addition, patients who are judged to have a problem to join this study.
研究者
相似试验
尚未招募
3 期
The effect of azithromycin 1 on the signs and symptoms of blepharitisBlepharitis.H01.0BlepharitisIRCT20190618043934N9Birjand University of Medical Sciences45
尚未招募
不适用
The safety and efficacy of azimycin 1% eye drops on patients with posterior blepharitis multi-center studyJPRN-UMIN000037713Itoh Clinic100
已完成
不适用
Clinical trial on the effect of Azyter in patients with blepharitis.BlepharitisNL-OMON2008930
招募中
Unknown
Treatment Protocol for Recurrent Cases of Bacterial Posterior BlepharitisblepharitisJPRN-jRCT1071230068ejima Ryohei50
进行中（未招募）
不适用
Study to Evaluate the Potential of Azithromycin to Cause Eye Problems in ChildreEUCTR2016-001119-19-Outside-EU/EEAPfizer Inc.30